Zydus chlorpromazine 100 mg tablets recalled over nitrosamine impurity above limit
Zydus Chlorpromazine Hydrochloride Tablets, USP, 100 mg, are recalled nationwide because N-Nitroso Desmethyl Chlorpromazine was found above the recommended acceptable intake limit.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Rubric level 3 covers risk-of-harm products where injury has not yet been reported; a nitrosamine above the recommended acceptable intake limit is a potential harm and no injuries are reported.
Plain-English summary
Chlorpromazine Hydrochloride Tablets, USP, 100 mg, in 100-count bottles and available on prescription only, manufactured by Zydus Lifesciences Ltd. in Baddi, India and distributed by Zydus Pharmaceuticals (USA) Inc. of Pennington, New Jersey, NDC 70710-1132-1, are being recalled. Affected lots include Z305079 and Z305080 expiring 30-09-25, and Z305454, Z305455, Z305457, Z400492, Z400493 and Z400494, with the full list in the recall notice. Distribution was nationwide.
The recall follows current good manufacturing practice deviations: the presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit. The FDA classified the action as Class II.
Patients should check the lot number on their bottle against the recall and should not stop taking a prescribed medicine without speaking to their pharmacist or prescriber about a replacement supply.
The recalled product
- Product
- CHLORPROMAZINE HYDROCHLORIDE (CHLORPROMAZINE HYDROCHLORIDE)
- Brand
- CHLORPROMAZINE HYDROCHLORIDE
- Manufacturer
- Zydus Pharmaceuticals (USA) Inc
- Category
- Drug — Central Nervous System
- Hazard
- nitrosamine-impurity
- cgmp-deviation
- prescription-drug
- class-ii
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: Z305079
- Z305080
- Exp Date 30-09-25
- Z305454
- Z305455
- Z305457
- Z400492
- Z400493
- Z400494
- Exp Date 31-12-25
- Z401158
- Z401725
- Z401726
- Exp. Date 28-02-26
- Z404118
- Z404119
- Z404120
- Exp Date 30-06-26
- Z405648
- Exp Date 30-09-26
UPCs (3)
- 0370710112912
- 0370710113216
- 0370710113018
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CHLORPROMAZINE HYDROCHLORIDE
- HighChlorpromazine 50 mg tablets recalled over nitrosamine above recommended intake limit
FDA (Drugs) · 2025-10-15
- HighChlorpromazine 200 mg tablets recalled over nitrosamine above recommended intake limit
FDA (Drugs) · 2025-10-15
- HighChlorpromazine 25 mg tablets recalled over nitrosamine above recommended intake limit
FDA (Drugs) · 2025-10-15
- HighChlorpromazine 25 mg fifty count packs recalled over nitrosamine impurity
FDA (Drugs) · 2025-10-15
- HighChlorpromazine tablets recalled over nitrosamine impurity above recommended intake limit
FDA (Drugs) · 2025-10-15
Same category
- HighXylocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateFDA Recalls Xylocaine Injections Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- HighNaropin Injection Recall Over Particulate Matter Contamination
FDA (Drugs) · 2026-07-29
- SevereMajor Pharmaceuticals Recalls Levothyroxine Sodium Tablets Over Subpotency
FDA (Drugs) · 2026-07-29
- SevereLevothyroxine Sodium Tablets Recalled for Subpotency Nationwide
FDA (Drugs) · 2026-07-29